AB
INBX icon

Amalgamated Bank’s Inhibrx INBX Stock Holding History

Amalgamated Bank’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-285
Closed -$23K – 2206
2025
Q4 		$23K Sell
285
-77
-21% -$5.25K ﹤0.01% 2056
2025
Q3 		$12K Hold
362
– – ﹤0.01% 2368
2025
Q2 		$5K Hold
362
– – ﹤0.01% 2750
2025
Q1 		$5K Hold
362
– – ﹤0.01% 2660
2024
Q4 		$6K Hold
362
– – ﹤0.01% 2662
2024
Q3 		$6K Hold
362
– – ﹤0.01% 2700
2024
Q2 		$5K Buy
+362
New +$5.66K ﹤0.01% 2772

Other funds holding INBX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Amalgamated Bank's INBX Position: Q1 2026 in Review

Amalgamated Bank sold out of Inhibrx (INBX) in Q1 2026, closing a stake of 285 shares — an estimated $23K sold.

Amalgamated Bank first reported a position in INBX in Q2 2024 and held it in 7 quarters. The position peaked at $23K in Q4 2025. 135 funds tracked by Wall St. Rank hold INBX as of Q1 2026.

  • Amalgamated Bank reported no remaining Inhibrx position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 285 Inhibrx shares in Q1 2026, an estimated $23K.
  • Amalgamated Bank first reported a position in Inhibrx in Q2 2024 and held it in 7 quarters.
  • Amalgamated Bank's Inhibrx position peaked at $23K in Q4 2025.
  • 135 funds tracked by Wall St. Rank held Inhibrx as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.